Chemical, biological and protein-receptor binding profiling of Bauhinia scandens L. stems provide new insights into the management of pain, inflammation, pyrexia and thrombosis

dc.contributor.authorEmon, Nazim Uddin
dc.contributor.authorRudra, Sajib
dc.contributor.authorAlam, Safaet
dc.contributor.authorAl Haidar, Ibrahim Khalil
dc.contributor.authorPaul, Susmita
dc.contributor.authorRichi, Fahmida Tasnim
dc.contributor.authorShahriar, Saimon
dc.contributor.authorSayeed, Mohammed Aktar
dc.contributor.authorTumpa, Nadia Islam
dc.contributor.authorGanguly, Amlan
dc.date.accessioned2021-09-27T08:36:52Z
dc.date.available2021-09-27T08:36:52Z
dc.date.issued2021-09-08
dc.description.abstractBauhinia scandens L. (Family, Fabaceae) is a medicinal plant used for conventional and societal medication in Ayurveda. The present study has been conducted to screen the chemical, pharmacological and biochemical potentiality of the methanol extracts of B. scandens stems (MEBS) along with its related fractions including carbon tetrachloride (CTBS), di-chloromethane (DMBS) and n-butanol (BTBS). UPLC-QTOF–MS has been implemented to analyze the chemical compounds of the methanol extracts of Bauhinia scandens stems. Additionally, antinociceptive and anti-inflammatory effects were performed by following the acetic acid-induced writhing test and formalin-mediated paw licking test in the mice model. The antipyretic investigation was performed by Brewer Yeast induced pyrexia method. The clot lysis method was implemented to screen the thrombolytic activity in human serum. Besides, the in silico study was performed for the five selected chemical compounds of Bauhinia scandens, found by UPLC-QTOF–MS By using Discover Studio 2020, UCSF Chimera, PyRx autodock vina and online tools. The MEBS and its fractions exhibited remarkable inhibition in dose dependant manner in the antinociceptive and antiinflammatory investigations. The antipyretic results of MEBS and DMBS were close to the standard drug indomethacin. Investigation of the thrombolytic effect of MEBS, CTBS, DMBS, and BTBS revealed notable clot-lytic potentials. Besides, the phenolic compounds of the plant extracts revealed strong binding affinity to the COX-1, COX-2, mPGES-1 and plasminogen activator enzymes. To recapitulate, based on the research work, Bauhinia scandens L. stem and its phytochemicals can be considered as prospective wellsprings for novel drug development and discovery by future researchers.en_US
dc.identifier.urihttp://dspace.iiuc.ac.bd:8080/xmlui/handle/123456789/2824
dc.language.isoenen_US
dc.publisher(http://creativecommons.org/licenses/by-nc-nd/4.0/).en_US
dc.subjectAnti-inflammatoryen_US
dc.subjectAntinociceptiveen_US
dc.subjectAntipyreticen_US
dc.subjectBauhinia scandensen_US
dc.subjectMolecular bindingen_US
dc.subjectUPLC-QTOF–MSen_US
dc.titleChemical, biological and protein-receptor binding profiling of Bauhinia scandens L. stems provide new insights into the management of pain, inflammation, pyrexia and thrombosisen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Bauhiniascandens-BiophaPharmacother2021-6.pdf
Size:
2.63 MB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: